BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -60.77% |
| Q3 2025 | 43.22% |
| Q2 2025 | 401.39% |
| Q1 2025 | -39.46% |
| Q4 2024 | 193.83% |
| Q3 2024 | 61.21% |
| Q2 2024 | 23.81% |
| Q1 2024 | -423.18% |
| Q4 2023 | 168.58% |
| Q3 2023 | 38.99% |
| Q2 2023 | -369.01% |
| Q1 2023 | -112.20% |
| Q4 2022 | -7.06% |
| Q3 2022 | -74.60% |
| Q2 2022 | -0.21% |
| Q1 2022 | -14.63% |
| Q4 2021 | -41.27% |
| Q3 2021 | 162.69% |
| Q2 2021 | 161.93% |
| Q1 2021 | -8.10% |
| Q4 2020 | 12.68% |
| Q3 2020 | -30.54% |
| Q2 2020 | -21.85% |
| Q1 2020 | -177.07% |
| Q4 2019 | -7.47% |
| Q3 2019 | -207.02% |
| Q2 2019 | 188.40% |
| Q1 2019 | -264.32% |
| Q4 2018 | -62.07% |
| Q3 2018 | -68.13% |
| Q2 2018 | 345.91% |
| Q1 2018 | -52.91% |
| Q4 2017 | 25.47% |
| Q3 2017 | -53.85% |
| Q2 2017 | 12.77% |
| Q1 2017 | -22.22% |
| Q4 2016 | 2786.19% |
| Q3 2016 | -31.79% |
| Q2 2016 | 116.41% |
| Q1 2016 | -96.19% |